Accelerate Productivity in 2025
Reignite Growth Despite the Global Slowdown
This Anti-Aging Market Report provides a comprehensive overview of the industry’s current state, growth rates, employment trends, patent activity, innovation hubs, and investment patterns. It highlights key hubs, top investors, and emerging startups to offer insights into the strategic movements defining anti-aging industry development globally.
These data points reflect emerging innovations, investment landscapes, and changing customer demand. It equips industry leaders, C-level executives, and corporates with actionable intelligence to make informed decisions.
Executive Summary: Anti-Aging Market Outlook 2025
- Industry Growth Overview: The global anti-aging market is projected to grow from USD 85.13 billion in 2025 to USD 119.84 billion by 2030, registering a compound annual growth rate (CAGR) of 7.08%. It expanded at an annual rate of 6.68% as per our platform data.
- Manpower & Employment Growth: The anti-aging sector employs over 381 300 professionals worldwide. In the past year, the industry added 30 400 new jobs.
- Patents & Grants: The sector holds 79 960+ patents, submitted by over 32 130 unique applicants. It received 351 research grants.
- Global Footprint: The USA, India, UK, Germany, and Canada rank as top country hubs. Key innovation cities include New York City, London, Singapore, New Delhi, and Sydney.
- Investment Landscape: The industry has closed 2261 funding rounds, backed by 1900+ investors, covering over 814 companies. The average investment per round stands at USD 13.8 million, reflecting high-growth expectations and long-term investor confidence.
- Top Investors: The top investors invested about USD 4.51 billion. Some of these investors include Yuri Milner (USD 954.1 million), Altitude Life Science Ventures (USD 500 million), Foresite Capital (USD 500 million), ARCH Venture Partners (USD 500 million), and Bridgepoint (USD 500 million).
- Startup Ecosystem: The five innovative startups in this sector include Ayucell – intracellular nicotinamide adenine dinucleotide in oxidized form (NAD+) science, Morphace – radiofrequency (RF) wearable, Barunbio – cell stimulation technology, Labareau – hyaluronic molecule-based technology, and Genflow Biosciences – sirtuin 6-targeted therapeutics.
Methodology: How we created this Anti-Aging Market Report
This report is based on proprietary data from our AI-powered StartUs Insights Discovery Platform, which tracks 7 million global companies, 20K+ technologies and trends as well as 150M patents, news articles, and market reports. This data includes detailed firmographic insights into approximately 7 million startups, scaleups, and tech companies. Leveraging this exhaustive database, we provide actionable insights for startup scouting, trend discovery, and technology landscaping.
For this report, we focused on the evolution of anti-aging over the past 5 years, utilizing our platform’s trend intelligence feature. Key data points analyzed include:
- Total Companies working in the sector
- News Coverage and Annual Growth
- Market Maturity and Patents
- Global Search Volume & Growth
- Funding Activity and Top Countries
- Subtrends within anti-aging
Our data is refreshed regularly, enabling trend comparisons for deeper insights into their relative impact and importance.
Additionally, we reviewed trusted external resources to supplement our findings with broader market data and predictions, ensuring a reliable and comprehensive overview of the anti-aging market.
What Data is used to create this Anti-Aging Report?
Based on data provided by the StartUs Insights Discovery Platform, we observe that the anti-aging market stands out in the following categories relative to the 20K+ technologies and trends we track.
These categories provide a comprehensive overview of the market’s key metrics and inform the future direction of the market.
- News Coverage & Publications: More than 1780 news articles were published about this sector in the last year.
- Funding Rounds: The sector closed more than 2260 funding rounds.
- Manpower: It includes a workforce of 381 300 professionals, and added about 30 400 employees in the last year.
- Patents: The industry holds more than 79 960 patents.
- Grants: A total of 351 research grants have been awarded in this space.
- Yearly Global Search Growth: The industry experienced a 7.64% increase in global online search interest in the last year.
Explore the Data-driven Anti-Aging Outlook for 2025
The anti-aging industry expanded with an annual rate of 6.68%. Our Discovery Platform records insights from 12 888 companies, including 999 startups driving innovation across segments like therapeutic, technological, and consumer wellness. More than 79 960 patents were filed while the sector received 351 research grants.
With a global manpower of 381 300 professionals and an annual workforce increase of 30 400 employees, talent flows concentrate in innovation hotspots.
The top country hubs are the USA, India, the UK, Germany, and Canada. New York City, London, Singapore, New Delhi, and Sydney emerge as the leading urban innovation centers.
The USA anti-aging products industry is projected to grow at a CAGR of 6.8% between 2025 and 2030. In 2024, Europe accounted for 28.3% of global market revenue. Additionally, the Asia Pacific region is expected to expand at a faster pace with a CAGR of 9.2% during the same forecast period.
By product category, moisturizers, creams, and lotions held the largest share, contributing 39.6% of industry revenue in 2024. Facial serums will grow with a projected CAGR of 9.1% from 2025 to 2030.
In terms of distribution, hypermarkets and supermarkets accounted for 32.2% of sales in 2024 through high footfall, product variety, and competitive pricing. The e-commerce channel is expected to register a CAGR of 9.4% between 2025 and 2030.
Anti-aging skincare products captured the largest market share by product type, accounting for 55% in 2023.
The global anti-aging market is projected to reach USD 85.13 billion in 2025 and grow to USD 119.84 billion by 2030, with a CAGR of 7.08%.
Credit: Mordor Intelligence
Moreover, the market size of the global senolytics and anti-aging pharmaceuticals market is projected to expand to USD 8.72 billion by 2034.
A Snapshot of the Global Anti-Aging Market
The anti-aging industry recorded an annual growth rate of 6.68%. Currently, 999 startups contribute to this momentum, with 290+ identified as early-stage ventures.
On the corporate development front, the industry underwent 340+ mergers and acquisitions (M&A).
Further, over 32 130 unique applicants filed more than 79 960 patents. This patent activity grew at a rate of 4.26% year-over-year (YoY).
China leads in patent issuance with 34 617 patents, followed by the USA at 10 661.
Explore the Funding Landscape of the Anti-Aging Market
The anti-aging industry continues to attract strong investor confidence, with an average investment value of USD 13.8 million per funding round – a clear signal of the sector’s high-growth potential and perceived long-term value.
So far, the industry has seen over 2260 funding rounds closed, fueling innovation across therapeutics, regenerative medicine, consumer health, and emerging biotech platforms.
This momentum is supported by a diverse and expanding investor base, with more than 1900 individual investors and institutions actively participating in the space. These backers have collectively invested in over 810 companies, spanning early-stage startups to more mature, acquisition-ready ventures.
Who is Investing in the Anti-Aging Market?
The combined investment value from the top investors in the anti-aging industry exceeds USD 4.51 billion.
- Yuri Milner invested USD 954.1 million in at least one company.
- Altitude Life Science Ventures allocated USD 500 million to at least one company.
- Foresite Capital also contributed USD 500 million toward at least one company.
- ARCH Venture Partners invested USD 500 million in at least one company.
- Bridgepoint also invested USD 500 million in a single firm.
- Hindustan Unilever invested USD 342 million in at least one company.
- Yunfeng Capital invested USD 304 million in one company.
- Boyu Capital allocated USD 304 million to at least one company.
- Alibaba also invested USD 304 million in at least one company.
- Suning.com invested USD 304 million in at least one company.
Top Anti-Aging Innovations & Trends
Discover the emerging trends in the anti-aging market along with their firmographic details:
- Microneedling: This domain expands at an annual growth rate of 4.57%. It is supported by 7197 companies, employs 118 700 people, and added 8000 new jobs over the past year. Its use in both clinical and consumer skincare highlights its importance as a non-invasive rejuvenation method.
- Biohacking: This sector grows at 13.70% annually. It comprises 1029 companies and a workforce of 18 700, with 3200 new employees joining in the last year. Its surge reflects the change toward personalized longevity strategies involving wearables, supplements, and performance tracking.
- Medical Peels: Though more niche, the medical peels domain maintains a steady growth at 1.58% annually. The segment includes 217 companies with 4100 employees, and added 221 new jobs in the past year. As a clinical-grade treatment used in dermatology, medical peels play a core role in professional skin renewal.
5 Top Examples from 950+ Innovative Anti-Aging Startups
The five innovative startups showcased below are picked based on data including the trend they operate within and their relevance, founding year, funding status, and more. Book a demo to find promising startups, emerging trends, or industry data specific to your company’s needs and objectives.
Ayucell follows Intracellular NAD+ Science
US-based startup Ayucell NAD⁺-enhancing products infused with nicotinamide riboside (NR) to support cellular energy metabolism. The products replenish NAD⁺ levels within cells, which naturally decrease with age and contribute to slower cell turnover, reduced collagen synthesis, impaired DNA repair, and increased inflammation.
NR functions as a precursor to NAD⁺ and enters the cell directly. This targeted delivery increases collagen production, supports skin renewal, and minimizes visible signs of aging.
Morphace builds an RF Wearable
Canadian startup Morphace develops a personalized, wearable RF skincare mask to reverse facial wrinkles by stimulating collagen and elastin production. The mask offers controlled RF energy deep into the dermis, where it heats skin tissue and activates fibroblasts to restore the skin’s structural integrity.
By remodeling the collagen network and supporting elastin regeneration, the startup reduces visible wrinkle depth, volume, and area across commonly affected regions such as the forehead, eye corners, and nasolabial folds. The hands-free mask integrates AI-based skin assessment and tailored treatment protocols to receive automated, clinically validated sessions.
Barunbio makes Cell Stimulation Technology
South Korean startup Barunbio makes WE-STIM, a wearable electric stimulation technology that activates cells through micro-electric fields generated by everyday human movement. When used in face patches or gels, the system uses ambient energy from body motion, surface contact, and surrounding electrical activity.
Further, it produces a localized alternating electric potential without requiring external devices or batteries. This continuous, low-intensity stimulation targets specific areas to promote cell activation.
Labareau develops Hyaluronic Molecule-based Technology
Dutch startup Labareau develops SAXZ-12, an anti-aging skincare technology that combines hyaluronic acid, peptides, and a concentrated native atelocollagen complex to support skin regeneration and hydration. The formula delivers medical-grade active ingredients deep into the skin.
Thus, the hyaluronic acid retains moisture, peptides stimulate the natural production of collagen and elastin, and native collagen restores structure, volume, and elasticity. Thus, this technology reduces fine lines, wrinkles, and pore visibility while improving skin texture and firmness.
Genflow Biosciences offers SIRT6-targeted Therapeutics
UK-based startup Genflow Biosciences makes GF-1002, a gene therapy that introduces a centenarian variant of the human SIRT6 gene to support healthy aging. The therapy uses adeno-associated virus (AAV) vectors in a 120-minute infusion to temporarily express additional copies of the SIRT6 gene.
This delivery method avoids integration into host DNA, eliminates the risk of self-replication, and prevents bacterial gene transfer to reduce potential immune responses or mutagenesis. Thus, the startup promotes long-term cellular resilience and improves the quality of aging.
Gain Comprehensive Insights into Anti-Aging Trends, Startups, and Technologies
The Anti-Aging Industry Report 2025 reveals an expanding field driven by strong investor interest, continuous patent activity, and a maturing global startup ecosystem.
It showcases advancements in biotechnology, personalized skincare, and minimally invasive treatments. With this, the industry now spans applications from gene delivery and cellular stimulation to digital diagnostics and remote therapeutics.
Get in touch to explore 950+ startups and scaleups, as well as all market trends impacting anti-aging companies.
